Cordeiro-Stone Marila, Nikolaishvili-Feinberg Nana
Department of Pathology and Laboratory Medicine, Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina,Chapel Hill, NC 27599-7525, USA.
Mutat Res. 2002 Dec 29;510(1-2):91-106. doi: 10.1016/s0027-5107(02)00255-5.
In vitro replication assays for detection and quantification of bypass of UV-induced DNA photoproducts were used to compare the capacity of extracts prepared from different human cell lines to replicate past the cis,syn cyclobutane thymine dimer ([c,s]TT). The results demonstrated that neither nucleotide excision repair (NER) nor mismatch repair (MMR) activities in the intact cells interfered with measurements of bypass replication efficiencies in vitro. Extracts prepared from HeLa (NER- and MMR-proficient), xeroderma pigmentosum group A (NER-deficient), and HCT116 (MMR-deficient) cells displayed similar capacity for translesion synthesis, when the substrate carried the site-specific [c,s]TT on the template for the leading or the lagging strand of nascent DNA. Extracts from xeroderma pigmentosum variant cells, which lack DNA polymerase eta, were devoid of bypass activity. Bypass-proficient extracts as a group (n=16 for 3 extracts) displayed higher efficiency (P=0.005) for replication past the [c,s]TT during leading strand synthesis (84+/-22%) than during lagging strand synthesis (64+/-13%). These findings are compared to previous results concerning the bypass of the (6-4) photoproduct [Biochemistry 40 (2001) 15215] and analyzed in the context of the reported characteristics of bypass DNA polymerases implicated in translesion synthesis of UV-induced DNA lesions. Models to explain how these enzymes might interact with the DNA replication machinery are considered. An alternative pathway of bypass replication, which avoids translesion synthesis, and the mutagenic potential of post-replication repair mechanisms that contribute to the duplication of the human genome damaged by UV are discussed.
利用体外复制分析来检测和定量紫外线诱导的DNA光产物的绕过情况,以比较从不同人类细胞系制备的提取物越过顺式、反式环丁烷胸腺嘧啶二聚体([c,s]TT)进行复制的能力。结果表明,完整细胞中的核苷酸切除修复(NER)和错配修复(MMR)活性均不干扰体外绕过复制效率的测量。当底物在新生DNA的前导链或后随链模板上携带位点特异性[c,s]TT时,从HeLa(NER和MMR功能正常)、A型着色性干皮病(NER缺陷)和HCT116(MMR缺陷)细胞制备的提取物显示出相似的跨损伤合成能力。缺乏DNA聚合酶η的着色性干皮病变异细胞的提取物没有绕过活性。作为一组的具有绕过活性的提取物(3种提取物共16个样本)在前导链合成过程中越过[c,s]TT进行复制的效率(P = 0.005)(84±22%)高于后随链合成过程(64±13%)。将这些发现与先前关于(6 - 4)光产物绕过的结果[《生物化学》40 (2001) 15215]进行了比较,并在报道的参与紫外线诱导的DNA损伤跨损伤合成的绕过DNA聚合酶特性的背景下进行了分析。考虑了解释这些酶如何与DNA复制机制相互作用的模型。讨论了一种避免跨损伤合成的绕过复制替代途径,以及有助于复制受紫外线损伤的人类基因组的复制后修复机制的诱变潜力。